VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Feb 01, 2017 To Feb 25, 2017:


Bacillus anthracis (Anthrax)

  1. Lv J, Zhang YY, Lu X, Zhang H, Wei L, Gao J, Hu B, Hu WW, Hu DZ, Jia N, Feng X. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice Biologicals : journal of the International Association of Biological Standardization 2017 [PMID: 28215694]
  2. Arora G, Misra R, Sajid A. Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis Current topics in medicinal chemistry 2017 [PMID: 28137237]
  3. Redd SC, Frieden TR. CDC's Evolving Approach to Emergency Response Health security 15(1):41-52 2017 [PMID: 28146366]
  4. Brannen DE, Branum M, Pawani S, Miller S, Bowman J, Clare T. Medical Allocations to Persons with Special Needs during a Bioterrorism Event Online journal of public health informatics 8(3):e200 2016 [PMID: 28210421]

Brucella (Brucellosis)

  1. Ron-Román J, Berkvens D, Barzallo-Rivadeneira D, Angulo-Cruz A, González-Andrade P, Minda-Aluisa E, Benítez-Ortíz W, Brandt J, Rodríguez-Hidalgo R, Saegerman C. The unexpected discovery of Brucella abortus Buck 19 vaccine in goats from Ecuador underlines the importance of biosecurity measures Tropical animal health and production 2017 [PMID: 28160160]
  2. Clausse M, Díaz AG, Pardo RP, Zylberman V, Goldbaum FA, Estein SM. Polymeric antigen BLSOmp31 in aluminium hydroxide induces serum bactericidal and opsonic antibodies against Brucella canis in dogs Veterinary immunology and immunopathology 184:36-41 2017 [PMID: 28166930]

Burkholderia mallei (Glanders)

  1. Saikh KU, Mott TM. Innate immune response to Burkholderia mallei Current opinion in infectious diseases 2017 [PMID: 28177960]

Burkholderia pseudomallei (Melioidosis)

  1. Shea AA, Bernhards RC, Cote CK, Chase CJ, Koehler JW, Klimko CP, Ladner JT, Rozak DA, Wolcott MJ, Fetterer DP, Kern SJ, Koroleva GI, Lovett SP, Palacios GF, Toothman RG, Bozue JA, Worsham PL, Welkos SL. Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences PloS one 12(2):e0171363 2017 [PMID: 28187198]
  2. Natesan M, Corea E, Krishnananthasivam S, Sathkumara HD, Dankmeyer JL, Dyas BK, Amemiya K, De Silva AD, Ulrich RG. Calprotectin as a biomarker for melioidosis disease progression and management Journal of clinical microbiology 2017 [PMID: 28179407]

Clostridium botulinum toxin (Botulism)

  1. Sierakowski J, Arthur J, Wylie T. Acute Hypotonia in an Infant The Journal of emergency medicine 2017 [PMID: 28174033]

Clostridium perfringens

  1. Goossens E, Valgaeren BR, Pardon B, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F. Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis Veterinary research 48(1):9 2017 [PMID: 28209206]
  2. Alves GG, Machado-de-Ávila RA, Chávez-Olórtegui CD, Silva RO, Lobato FC. Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2017 [PMID: 28223027]
  3. Aziminia P, Pilehchian-Langroudi R, Esmaeilnia K. Cloning and expression of <i>Clostridium perfringens</i> type D vaccine strain epsilon toxin gene in <i>E. coli</i> as a recombinant vaccine candidate Iranian journal of microbiology 8(4):226-231 2016 [PMID: 28210460]

Cryptosporidium parvum

  1. Teotia P, Prakash Dwivedi S, Dwivedi N. A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum Bioinformation 12(3):119-123 2016 [PMID: 28149045]

Eastern equine encephalitis virus

  1. Porter AI, Erwin-Cohen RA, Twenhafel N, Chance T, Yee SB, Kern SJ, Norwood D, Hartman LJ, Parker MD, Glass PJ, DaSilva L. Characterization and pathogenesis of aerosolized eastern equine encephalitis in the common marmoset (Callithrix jacchus) Virology journal 14(1):25 2017 [PMID: 28173871]

Ebola virus

  1. Snape MD. Persistence of immune responses induced by Ebola virus vaccines The Lancet. Global health 5(3):e238-e239 2017 [PMID: 28193382]
  2. Wilkinson DE, Page M, Mattiuzzo G, Hassall M, Dougall T, Rigsby P, Stone L, Minor P. Comparison of platform technologies for assaying antibody to Ebola virus Vaccine 35(9):1347-1352 2017 [PMID: 28161420]
  3. Lehrer AT, Wong TS, Lieberman MM, Humphreys T, Clements DE, Bakken RR, Hart MK, Pratt WD, Dye JM. Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice Vaccine 2017 [PMID: 28216187]
  4. Maslow JN. Vaccine development for emerging virulent infectious diseases Vaccine 2017 [PMID: 28216184]
  5. Martin B, Canard B, Decroly E. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle Antiviral research 2017 [PMID: 28192094]
  6. Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens Globalization and health 13(1):9 2017 [PMID: 28179007]
  7. Khurana S, Fuentes S, Coyle EM, Ravichandran S, Davey RT Jr, Beigel JH. Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies Nature medicine 23(2):264 2017 [PMID: 28170379]
  8. Li H, Yu F, Xia S, Yu Y, Wang Q, Lv M, Wang Y, Jiang S, Lu L. Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Virus-like Particles Antimicrobial agents and chemotherapy 2017 [PMID: 28167539]
  9. Miller KD, Rall GF. What Kaplan-Meier survival curves don't tell us about CNS disease Journal of neuroimmunology 2017 [PMID: 28187911]
  10. Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Tokarskaya EA, Simakova YV, Egorova DA, Scherbinin DN, Tutykhina IL, Lysenko AA, Kostarnoy AV, Gancheva PG, Ozharovskaya TA, Belugin BV, Kolobukhina LV, Pantyukhov VB, Syromyatnikova SI, Shatokhina IV, Sizikova TV, Rumyantseva IG, Andrus AF, Boyarskaya NV, Voytyuk AN, Babira VF, Volchikhina SV, Kutaev DA, Bel'skih AN, Zhdanov KV, Zakharenko SM, Borisevich SV, Logunov DY, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia Human vaccines & immunotherapeutics :1-8 2017 [PMID: 28152326]
  11. Mullard A. Ebola vaccine success Nature reviews. Drug discovery 16(2):77 2017 [PMID: 28148944]
  12. DuPont HL. Emerging Infectious Diseases, Animals, and Future Epidemics Texas medicine 113(2):31-36 2017 [PMID: 28207078]
  13. M Alam El-Din H, A Loutfy S, Fathy N, H Elberry M, M Mayla A, Kassem S, Naqvi A. Molecular docking based screening of compounds against VP40 from Ebola virus Bioinformation 12(3):192-196 2016 [PMID: 28149054]

Escherichia coli

  1. Liu G, Yin J, Barkema HW, Chen L, Shahid M, Szenci O, De Buck J, Kastelic JP, Han B. Development of a single-dose recombinant CAMP factor entrapping poly(lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae Vaccine 35(9):1246-1253 2017 [PMID: 28162819]
  2. Deb A, Johnson WA, Kline AP, Scott BJ, Meador LR, Srinivas D, Martin-Garcia JM, Dörner K, Borges CR, Misra R, Hogue BG, Fromme P, Mor TS. Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide PloS one 12(2):e0172529 2017 [PMID: 28225803]
  3. Lei J, Shi T, Sun D, Mo K, Yan Y, Jin Y, Liao M, Zhou J. Development and application of nsp5-ELISA for the detection of antibody to infectious bronchitis virus Journal of virological methods 2017 [PMID: 28223026]
  4. Sączyńska V, Romanik A, Florys K, Cecuda-Adamczewska V, Kęsik-Brodacka M, Śmietanka K, Olszewska M, Domańska-Blicharz K, Minta Z, Szewczyk B, Płucienniczak G, Płucienniczak A. A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies PloS one 12(2):e0172008 2017 [PMID: 28212428]
  5. Paul G, Deshmukh A, Kaur I, Rathore S, Dabral S, Panda A, Singh SK, Mohmmed A, Theisen M, Malhotra P. A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites Malaria journal 16(1):79 2017 [PMID: 28202027]
  6. Tobias J, Lebens M, Wai SN, Holmgren J, Svennerholm AM. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens Microbial pathogenesis 2017 [PMID: 28215587]
  7. Watkins HC, Rappazzo CG, Higgins JS, Sun X, Brock N, Chau A, Misra A, Cannizzo JP, King MR, Maines TR, Leifer CA, Whittaker GR, DeLisa MP, Putnam D. Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection Molecular therapy : the journal of the American Society of Gene Therapy 2017 [PMID: 28215994]
  8. Marana MH, Jørgensen LV, Skov J, Chettri JK, Holm Mattsson A, Dalsgaard I, Kania PW, Buchmann K. Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss PloS one 12(2):e0171944 2017 [PMID: 28182704]
  9. Hanapi UF, Yong CY, Goh ZH, Alitheen NB, Yeap SK, Tan WS. Tracking the virus-like particles of <i>Macrobrachium rosenbergii</i> nodavirus in insect cells PeerJ 5:e2947 2017 [PMID: 28194311]
  10. Meza B, Ascencio F, Sierra-Beltrán AP, Torres J, Angulo C. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 49:309-317 2017 [PMID: 28185986]
  11. Zhao JZ, Xu LM, Liu M, Cao YS, LaPatra SE, Yin JS, Liu HB, Lu TY. An efficient and simple method to increase the level of displayed protein on the yeast cell surface Journal of microbiological methods 135:41-47 2017 [PMID: 28188810]
  12. Jennings MC, Tilley DH, Ballard SB, Villanueva M, Costa FM, Lopez M, Steinberg HE, Giannina Luna C, Meza R, Silva ME, Gilman RH, Simons MP, Maves RC, Cabada MM. Case-Case Analysis Using 7 Years of Travelers' Diarrhea Surveillance Data: Preventive and Travel Medicine Applications in Cusco, Peru The American journal of tropical medicine and hygiene 2017 [PMID: 28167602]
  13. Song B, Yang X, Sun H, Yu L, Ma J, Wu Z, Cui Y. Immunogenicity of amino acids 1-150 of Streptococcus GapC displayed on the surface of Escherichia coli Microbial pathogenesis 2017 [PMID: 28179116]
  14. Ghanbarpour R, Askari N, Ghorbanpour M, Tahamtan Y, Mashayekhi K, Afsharipour N, Darijani N. Genotypic analysis of virulence genes and antimicrobial profile of diarrheagenic Escherichia coli isolated from diseased lambs in Iran Tropical animal health and production 2017 [PMID: 28161846]
  15. Bielaszewska M, Rüter C, Bauwens A, Greune L, Jarosch KA, Steil D, Zhang W, He X, Lloubes R, Fruth A, Kim KS, Schmidt MA, Dobrindt U, Mellmann A, Karch H. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury PLoS pathogens 13(2):e1006159 2017 [PMID: 28158302]
  16. Lin R, Zhu B, Zhang Y, Bai Y, Zhi F, Long B, Li Y, Wu Y, Wu X, Fan H. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice Microbial pathogenesis 105:19-24 2017 [PMID: 28163157]
  17. Won G, Kim TH, Lee JH. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli BMC veterinary research 13(1):40 2017 [PMID: 28143511]
  18. Fernandes LG, Teixeira AF, Filho AF, Souza GO, Vasconcellos SA, Heinemann MB, Romero EC, Nascimento AL. Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017 [PMID: 28161462]
  19. Lee CH, Hajishengallis G, Connell TD. Dendritic cell-mediated mechanisms triggered by LT-IIa-B₅, a mucosal adjuvant derived from a type II heat-labile enterotoxin of <i>Escherichia coli</i> Journal of microbiology and biotechnology 2017 [PMID: 28144014]
  20. Sachdeva S, Palur RV, Sudhakar KU, Rathinavelan T. <i>E. coli</i> Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance Frontiers in microbiology 8:70 2017 [PMID: 28217109]
  21. Fan X, Yue Y, Xiong S. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis Antiviral research 140:121-132 2017 [PMID: 28137624]
  22. He W, Shu J, Zhang J, Liu Z, Xu J, Jin X, Wang X. Expression, purification and renaturation of recombinant peptide-based HIV vaccine in Escherichia coli Canadian journal of microbiology 2017 [PMID: 28177783]
  23. Liu F, Tang X, Sheng X, Xing J, Zhan W. Construction and evaluation of an Edwardsiella tarda DNA vaccine encoding outer membrane protein C Microbial pathogenesis 104:238-247 2017 [PMID: 28137507]
  24. Makvandi M, Teimoori A, Neisi N, Samarbafzadeh A. Designing, Construction and Expression of a Recombinant Fusion Protein Comprising the Hepatitis E Virus ORF2 and Rotavirus NSP4 in the Baculovirus Expression System Jundishapur journal of microbiology 9(11):e40303 2016 [PMID: 28138375]
  25. Farsad AS, Malekzadeh-Shafaroudi S, Moshtaghi N, Fotouhi F, Zibaee S. Expression of HA1 antigen of H5N1 influenza virus as a potent candidate for vaccine in bacterial system Iranian journal of veterinary research 17(4):237-242 2016 [PMID: 28224006]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Newman LM, Gottlieb SL. First estimates of the global and regional incidence of neonatal herpes infection The Lancet. Global health 5(3):e300-e309 2017 [PMID: 28153513]
  2. Cohen C, von Mollendorf C, de Gouveia L, Lengana S, Meiring S, Quan V, Nguweneza A, Moore DP, Reubenson G, Moshe M, Madhi SA, Eley B, Hallbauer U, Finlayson H, Varughese S, O'Brien KL, Zell ER, Klugman KP, Whitney CG, von Gottberg A. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study The Lancet. Global health 5(3):e359-e369 2017 [PMID: 28139443]
  3. Raghavendran A, Hernandez AL, Lensing S, Gnanamony M, Karthik R, Sivasubramanian M, Kannangai R, Abraham P, Mathai D, Palefsky JM. Genital Human Papillomavirus Infection in Indian HIV-Seropositive Men Who Have Sex With Men Sexually transmitted diseases 44(3):173-180 2017 [PMID: 28178116]
  4. Deb A, Johnson WA, Kline AP, Scott BJ, Meador LR, Srinivas D, Martin-Garcia JM, Dörner K, Borges CR, Misra R, Hogue BG, Fromme P, Mor TS. Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide PloS one 12(2):e0172529 2017 [PMID: 28225803]
  5. Irimia A, Serra AM, Sarkar A, Jacak R, Kalyuzhniy O, Sok D, Saye-Francisco KL, Schiffner T, Tingle R, Kubitz M, Adachi Y, Stanfield RL, Deller MC, Burton DR, Schief WR, Wilson IA. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design PLoS pathogens 13(2):e1006212 2017 [PMID: 28225819]
  6. Ma C, Claude KM, Kibendelwa ZT, Brooks H, Zheng X, Hawkes M. Is maternal education a social vaccine for childhood malaria infection? A cross-sectional study from war-torn Democratic Republic of Congo Pathogens and global health :1-9 2017 [PMID: 28220714]
  7. Jaworski JP, Bryk P, Brower Z, Zheng B, Hessell AJ, Rosenberg AF, Wu TT, Sanz I, Keefer MC, Haigwood NL, Kobie JJ. Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques PloS one 12(2):e0172524 2017 [PMID: 28222180]
  8. Kahn JA, Lee J, Belzer M, Palefsky JM. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination AIDS and behavior 2017 [PMID: 28220313]
  9. Liu Q, Acharya P, Dolan MA, Zhang P, Guzzo C, Lu J, Kwon A, Gururani D, Miao H, Bylund T, Chuang GY, Druz A, Zhou T, Rice WJ, Wigge C, Carragher B, Potter CS, Kwong PD, Lusso P. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer Nature structural & molecular biology 2017 [PMID: 28218750]
  10. Pymm P, Illing PT, Ramarathinam SH, O'Connor GM, Hughes VA, Hitchen C, Price DA, Ho BK, McVicar DW, Brooks AG, Purcell AW, Rossjohn J, Vivian JP. MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape Nature structural & molecular biology 2017 [PMID: 28218747]
  11. Nie J, Wu X, Ma J, Cao S, Huang W, Liu Q, Li X, Li Y, Wang Y. Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system Scientific reports 7:42769 2017 [PMID: 28218278]
  12. Kalk E, Schubert P, Bettinger JA, Cotton MF, Esser M, Slogrove A, Wright CA. Placental pathology in HIV infection at term: a comparison with HIV-uninfected women Tropical medicine & international health : TM & IH 2017 [PMID: 28214384]
  13. Rujas E, Caaveiro JM, Insausti S, García-Porras M, Tsumoto K, Nieva JL. Peripheral Membrane Interactions Boost the Engagement by an Anti HIV-1 Broadly Neutralizing Antibody The Journal of biological chemistry 2017 [PMID: 28213514]
  14. Williams C. Response to Glinka et al. "Timing matters - influenza vaccination to HIV-infected patients" HIV medicine 2017 [PMID: 28205375]
  15. Andrews JR, Nemes E, Tameris M, Landry BS, Mahomed H, McClain JB, Fletcher HA, Hanekom WA, Wood R, McShane H, Scriba TJ, Hatherill M. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study The Lancet. Respiratory medicine 2017 [PMID: 28215501]
  16. Kiwanuka N, Ssetaala A, Ssekandi I, Nalutaaya A, Kitandwe PK, Ssempiira J, Bagaya BS, Balyegisawa A, Kaleebu P, Hahn J, Lindan C, Sewankambo NK. Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda PloS one 12(2):e0171200 2017 [PMID: 28207844]
  17. Pancera M, Changela A, Kwong PD. How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design Current opinion in HIV and AIDS 2017 [PMID: 28207490]
  18. Noto A, Pantaleo G. B-cell abnormalities and impact on antibody response in HIV infection Current opinion in HIV and AIDS 2017 [PMID: 28207489]
  19. McCoy LE, McKnight Á. Lessons learned from humoral responses of HIV patients Current opinion in HIV and AIDS 2017 [PMID: 28207488]
  20. Ruprecht RM, Lakhashe SK. Antibody-mediated immune exclusion of HIV Current opinion in HIV and AIDS 2017 [PMID: 28207487]
  21. Asbach B, Wagner R. Particle-based delivery of the HIV envelope protein Current opinion in HIV and AIDS 2017 [PMID: 28207486]
  22. Martinez DR, Vandergrift N, Douglas AO, McGuire E, Bainbridge J, Nicely NI, Montefiori DC, Tomaras GD, Fouda GG, Permar SR. Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk Journal of virology 2017 [PMID: 28202762]
  23. Go EP, Ding H, Zhang S, Ringe RP, Nicely N, Hua D, Steinbock RT, Golabek M, Alin J, Alam SM, Cupo A, Haynes BF, Kappes JC, Moore JP, Sodroski JG, Desaire H. A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers Journal of virology 2017 [PMID: 28202756]
  24. Zurawski G, Shen X, Zurawski S, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Klucar P, Wang Z, Foulds KE, Kao SF, Yu X, Sato A, Yates NL, LaBranche C, Stanfield-Oakley S, Kibler K, Jacobs B, Salazar A, Self S, Fulp J, Gottardo R, Galmin L, Weiss D, Cristillo A, Pantaleo G, Levy Y. Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses Journal of virology 2017 [PMID: 28202751]
  25. Takata H, Buranapraditkun S, Kessing C, Fletcher JL, Muir R, Tardif V, Cartwright P, Vandergeeten C, Bakeman W, Nichols CN, Pinyakorn S, Hansasuta P, Kroon E, Chalermchai T, O'Connell R, Kim J, Phanuphak N, Robb ML, Michael NL, Chomont N, Haddad EK, Ananworanich J, Trautmann L. Delayed differentiation of potent effector CD8<sup>+</sup> T cells reducing viremia and reservoir seeding in acute HIV infection Science translational medicine 9(377) 2017 [PMID: 28202771]
  26. Temchura V, Überla K. Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines Current opinion in HIV and AIDS 2017 [PMID: 28207491]
  27. Kitawi RC, Hunja CW, Aman R, Ogutu BR, Muigai AW, Kokwaro GO, Ochieng W. Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART Virology journal 14(1):29 2017 [PMID: 28196510]
  28. Wagner TA, Huang HC, Salyer CE, Richardson KM, Weinberg A, Nachman S, Frenkel LM. H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir AIDS research and therapy 14(1):7 2017 [PMID: 28193244]
  29. Hanson BM, Dorais JA. Reproductive considerations in the setting of chronic viral illness American journal of obstetrics and gynecology 2017 [PMID: 28209492]
  30. Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND) Heliyon 3(2):e00245 2017 [PMID: 28224137]
  31. Newman LP, Njoroge A, Magaret A, Chohan BH, Gitomea VW, Wald A, Gorstein J, Overbaugh J, Wamalwa D, Maleche-Obimbo E, Nduati R, Farquhar C. Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya The Pediatric infectious disease journal 2017 [PMID: 28198789]
  32. Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, Mulligan MJ, Koblin B, Buchbinder SP, Keefer MC, Adams E, Anude C, Corey L, Sobieszczyk M, Hammer SM, Gilbert PB, McElrath MJ. Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial The Journal of infectious diseases 2017 [PMID: 28199679]
  33. Murray JM, Maher S, Mota T, Suzuki K, Kelleher AD, Center RJ, Purcell D. Differentiating founder and chronic HIV envelope sequences PloS one 12(2):e0171572 2017 [PMID: 28187204]
  34. Islami F, Torre LA, Drope JM, Ward EM, Jemal A. Global cancer in women: Cancer control priorities Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 [PMID: 28183824]
  35. Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minichini C, Di Caprio G, Starace M, Onorato L, Signoriello G, Macera M, Angelillo IF, Pasquale G, Sagnelli E. Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features Infectious diseases of poverty 6(1):33 2017 [PMID: 28179020]
  36. Cerini F, Offord RE, McGowan I, Hartley O. Stability of 5P12-RANTES, a candidate rectal microbicide, in human rectal lavage AIDS research and human retroviruses 2017 [PMID: 28177261]
  37. Donkor ES, Annan JA, Badoe EV, Dayie NT, Labi AK, Slotved HC. Pneumococcal carriage among HIV infected children in Accra, Ghana BMC infectious diseases 17(1):133 2017 [PMID: 28178935]
  38. García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Lee C, Kibler KV, Jacobs BL, Wagner R, Ding S, Pantaleo G, Esteban M. HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell immune functions in non-human primates Journal of virology 2017 [PMID: 28179536]
  39. Tsai A, Irrinki A, Kaur J, Cihlar T, Kukolj G, Sloan DD, Murry JP. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy Journal of virology 2017 [PMID: 28179531]
  40. Yue FY, Cohen JC, Ho M, Rahman AK, Liu J, Mujib S, Saiyed A, Hundal S, Khozin A, Bonner P, Liu D, Benko E, Kovacs C, Ostrowski M. HIV-specific granzyme B, but not interferon-γ secreting T Cells are associated with reduced viral reservoirs in early HIV infection Journal of virology 2017 [PMID: 28179527]
  41. Alipour S, Mahdavi A, Abdoli A. The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat based candidate vaccines in mice Pathogens and disease 2017 [PMID: 28175274]
  42. Apostólico JS, Lunardelli VA, Yamamoto MM, Souza HF, Cunha-Neto E, Boscardin SB, Rosa DS. Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine Frontiers in immunology 8:101 2017 [PMID: 28223987]
  43. Warren E, Teskey G, Venketaraman V. Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection Journal of clinical medicine 6(2) 2017 [PMID: 28178208]
  44. Uprety P, Lindsey JC, Levin MJ, Rainwater-Lovett K, Ziemniak C, Bwakura-Dangarembizix M, Kaplan SS, Nelson M, Zadzilka A, Weinberg A, Persaud D. Inflammation and Immune Activation in Antiretroviral-Treated HIV-1-Infected African Infants and Rotavirus Vaccine Responses The Journal of infectious diseases 2017 [PMID: 28168269]
  45. Lockwood J, Gray J, Selvey C. Undiagnosed hepatitis B and C infection is rare in Sydney gay and bisexual men attending a community HIV testing site Sexual health 2017 [PMID: 28160785]
  46. Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, Nadas A, Kong XP, Zolla-Pazner S, Hioe CE. Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination Vaccine 2017 [PMID: 28185743]
  47. Ferrando-Martinez S, De Pablo-Bernal RS, De Luna-Romero M, De Ory SJ, Genebat M, Pacheco YM, Parras FJ, Montero M, Blanco JR, Gutierrez F, Santos J, Vidal F, Koup R, Muñoz-Fernández MÁ, Leal M, Ruiz-Mateos E. Thymic function failure is associated with HIV-disease progression Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 28158588]
  48. Kwong PD. What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective Cold Spring Harbor perspectives in biology 2017 [PMID: 28159876]
  49. Burton DR. What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise Cold Spring Harbor perspectives in biology 2017 [PMID: 28159875]
  50. Wieland U, Kreuter A. [Genital warts in HIV-infected individuals] Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2017 [PMID: 28160045]
  51. Dang MD, Nguyen DM, Tran HB, Pham VH, Spak D, Pham LC, Phan TQ, Dinh TT, Le TK, Nguyen VL, Le TH, Hoang SN, Dang VP. Clinical characteristics of pediatric HIV-1 patients treated with first-line antiretroviral therapy in Vietnam: a nested case-control study International journal of public health 2017 [PMID: 28160044]
  52. Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles Journal of immunological methods 2017 [PMID: 28163018]
  53. Lovelace ES, Maurice NJ, Miller HW, Slichter CK, Harrington R, Magaret A, Prlic M, De Rosa S, Polyak SJ. Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells PloS one 12(2):e0171139 2017 [PMID: 28158203]
  54. Mylvaganam GH, Rios D, Abdelaal HM, Iyer S, Tharp G, Mavinger M, Hicks S, Chahroudi A, Ahmed R, Bosinger SE, Williams IR, Skinner PJ, Velu V, Amara RR. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28159893]
  55. Millman AJ, Greenbaum A, Walaza S, Cohen AL, Groome MJ, Reed C, McMorrow M, Tempia S, Venter M, Treurnicht FK, Madhi SA, Cohen C, Variava E. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011 BMC pulmonary medicine 17(1):28 2017 [PMID: 28148246]
  56. Witt KC, Castillo-Menendez L, Ding H, Espy N, Zhang S, Kappes JC, Sodroski J. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs PloS one 12(2):e0170672 2017 [PMID: 28151945]
  57. Hogg R, Nkala B, Dietrich J, Collins A, Closson K, Cui Z, Kanters S, Chia J, Barhafuma B, Palmer A, Kaida A, Gray G, Miller C. Conspiracy beliefs and knowledge about HIV origins among adolescents in Soweto, South Africa PloS one 12(2):e0165087 2017 [PMID: 28151937]
  58. Compton AA, Schwartz O. They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection? PLoS pathogens 13(2):e1006099 2017 [PMID: 28152024]
  59. Bekri S, Bourdely P, Luci C, Dereuddre-Bosquet N, Su B, Martinon F, Braud VM, Luque I, Mateo PL, Crespillo S, Conejero-Lara F, Moog C, Le Grand R, Anjuère F. Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates Frontiers in immunology 8:63 2017 [PMID: 28203239]
  60. Li WX, Xia JA, Zhou X, Ma Y, Shen G, Qiu FW. Association of HLA alleles (A, B, DRB1) and HIV-1 infection in the Han population of Hubei, China Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 37(1):131-139 2017 [PMID: 28224433]
  61. Nasar F, Matassov D, Seymour RL, Latham T, Gorchakov RV, Nowak RM, Leal G, Hamm S, Eldridge JH, Tesh RB, Clarke DK, Weaver SC. Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal alphavirus challenge Journal of virology 2017 [PMID: 28148802]
  62. Li H, Zony C, Chen P, Chen BK. Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder Envs Journal of virology 2017 [PMID: 28148796]
  63. Wee EG, Ondondo B, Berglund P, Archer J, McMichael AJ, Baltimore D, Ter Meulen JH, Hanke T. HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells Molecular therapy : the journal of the American Society of Gene Therapy 25(2):494-503 2017 [PMID: 28153096]
  64. Obringer E, Walsh L. Infectious Diseases and Immunizations in International Adoption Pediatric annals 46(2):e56-e60 2017 [PMID: 28192579]
  65. He W, Shu J, Zhang J, Liu Z, Xu J, Jin X, Wang X. Expression, purification and renaturation of recombinant peptide-based HIV vaccine in Escherichia coli Canadian journal of microbiology 2017 [PMID: 28177783]
  66. Clinton C, Sridhar D. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance Lancet (London, England) 2017 [PMID: 28139255]
  67. Martin-Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb KE, Schulze Zur Wiesch J, Cubas R, Porichis F, Shalek AK, van Lunzen J, Haddad EK, Walker BD, Kaufmann DE, Lichterfeld M, Yu XG. Circulating CXCR5<sup>+</sup>CXCR3<sup>+</sup>PD-1<sup>lo</sup> Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth JCI insight 2(2):e89574 2017 [PMID: 28138558]
  68. Sotgiu G, Sulis G, Matteelli A. Tuberculosis-a World Health Organization Perspective Microbiology spectrum 5(1) 2017 [PMID: 28185618]
  69. Scriba TJ, Coussens AK, Fletcher HA. Human Immunology of Tuberculosis Microbiology spectrum 5(1) 2017 [PMID: 28155806]
  70. Chiabi A, Malangue B, Nguefack S, Dongmo FN, Fru F, Takou V, Angwafo F 3rd. The clinical spectrum of severe acute malnutrition in children in Cameroon: a hospital-based study in Yaounde, Cameroon Translational pediatrics 6(1):32-39 2017 [PMID: 28164028]
  71. Gilbert PB, Huang Y. Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine Efficacy Epidemiologic methods 5(1):93-9112 2016 [PMID: 28154793]
  72. Bailey JK, Nguyen DN, Horiya S, Krauss IJ. Synthesis of multivalent glycopeptide conjugates that mimic an HIV epitope Tetrahedron 72(40):6091-6098 2016 [PMID: 28190897]
  73. Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S, Afari EA. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana The Pan African medical journal 25(Suppl 1):7 2016 [PMID: 28210375]

Lassa virus

  1. Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens Globalization and health 13(1):9 2017 [PMID: 28179007]

Marburg virus

  1. Martin B, Canard B, Decroly E. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle Antiviral research 2017 [PMID: 28192094]
  2. Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens Globalization and health 13(1):9 2017 [PMID: 28179007]

Mycobacterium tuberculosis (tuberculosis)

  1. Ganesh K, Allam M, Wolter N, Bratcher HB, Harrison OB, Lucidarme J, Borrow R, de Gouveia L, Meiring S, Birkhead M, Maiden MC, von Gottberg A, du Plessis M. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa BMC microbiology 17(1):40 2017 [PMID: 28222677]
  2. Decout A, Silva-Gomes S, Drocourt D, Barbe S, André I, Cueto FJ, Lioux T, Sancho D, Pérouzel E, Vercellone A, Prandi J, Gilleron M, Tiraby G, Nigou J. Rational design of adjuvants targeting the C-type lectin Mincle Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28223515]
  3. Kulkarni S, Mukherjee S, Pandey A, Dahake R, Padmanabhan U, Chowdhary AS. Bacillus Calmette-Guérin Confers Neuroprotection in a Murine Model of Japanese Encephalitis Neuroimmunomodulation 2017 [PMID: 28208151]
  4. Andrews JR, Nemes E, Tameris M, Landry BS, Mahomed H, McClain JB, Fletcher HA, Hanekom WA, Wood R, McShane H, Scriba TJ, Hatherill M. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study The Lancet. Respiratory medicine 2017 [PMID: 28215501]
  5. Norrby M, Vesikari T, Lindqvist L, Maeurer M, Ahmed R, Mahdavifar S, Bennett S, McClain JB, Shepherd BM, Li D, Hokey DA, Kromann I, Hoff ST, Andersen P, de Visser AW, Joosten SA, Ottenhoff TH, Andersson J, Brighenti S. Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials Vaccine 2017 [PMID: 28216183]
  6. Díaz DP, Ocampo M, Varela Y, Curtidor H, Patarroyo MA, Patarroyo ME. Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion Molecular and cellular biochemistry 2017 [PMID: 28205097]
  7. Narváez J, Osorio MB, Castañeda-Orjuela C, Alvis Zakzuk N, Cediel N, Chocontá-Piraquive LÁ, de La Hoz-Restrepo F. Is Colombia reaching the goals on infant immunization coverage? A quantitative survey from 80 municipalities Vaccine 2017 [PMID: 28209436]
  8. Valentini D, Rao M, Ferrara G, Perkins M, Dodoo E, Zumla A, Maeurer M. Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017 [PMID: 28192214]
  9. Patterson S, Drewe JA, Pfeiffer DU, Clutton-Brock TH. Social and environmental factors affect tuberculosis related mortality in wild meerkats The Journal of animal ecology 2017 [PMID: 28186336]
  10. Choi HG, Choi S, Back YW, Paik S, Park HS, Kim WS, Kim H, Cha SB, Choi CH, Shin SJ, Kim HJ. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice Oncotarget 2017 [PMID: 28193909]
  11. Islami F, Torre LA, Drope JM, Ward EM, Jemal A. Global cancer in women: Cancer control priorities Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 [PMID: 28183824]
  12. Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, de Libero G, Williams A, Puzo G, Gilleron M. Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis Vaccine 2017 [PMID: 28190740]
  13. Zhang M, Dong C, Xiong S. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose Frontiers in cellular and infection microbiology 7:34 2017 [PMID: 28224119]
  14. Warren E, Teskey G, Venketaraman V. Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection Journal of clinical medicine 6(2) 2017 [PMID: 28178208]
  15. Bielecka MK, Tezera LB, Zmijan R, Drobniewski F, Zhang X, Jayasinghe S, Elkington P. A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in Tuberculosis mBio 8(1) 2017 [PMID: 28174307]
  16. Ameni G, Tafess K, Zewde A, Eguale T, Tilahun M, Hailu T, Sirak A, Salguero FJ, Berg S, Aseffa A, Hewinson RG, Vordermeier HM. Vaccination of calves with Mycobacterium bovis Bacillus Calmette-Guerin reduces the frequency and severity of lesions of bovine tuberculosis under a natural transmission setting in Ethiopia Transboundary and emerging diseases 2017 [PMID: 28168855]
  17. Cardona PJ, Williams A. Experimental animal modelling for TB vaccine development International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017 [PMID: 28163168]
  18. Tientcheu LD, Koch A, Ndengane M, Andoseh G, Kampmann B, Wilkinson RJ. Immunological consequences of strain variation within the Mycobacterium Tuberculosis complex European journal of immunology 2017 [PMID: 28150302]
  19. Rao M, Cadieux N, Fitzpatrick M, Reed S, Arsenian S, Valentini D, Parida S, Dodoo E, Zumla A, Maeurer M. Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017 [PMID: 28161464]
  20. Valentini D, Rao M, Rane L, Rahman S, Axelsson-Robertson R, Heuchel R, Löhr M, Hoft D, Brighenti S, Zumla A, Maeurer M. Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017 [PMID: 28161459]
  21. Bolursaz MR, Lotfian F, Velayati AA. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital Allergologia et immunopathologia 2017 [PMID: 28161281]
  22. Rizzi C, Peiter AC, Oliveira TL, Seixas AC Neto, Leal KS, Hartwig DD, Seixas FK, Borsuk S, Dellagostin OA. Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin Memorias do Instituto Oswaldo Cruz 112(2):123-130 2017 [PMID: 28177046]
  23. Obringer E, Walsh L. Infectious Diseases and Immunizations in International Adoption Pediatric annals 46(2):e56-e60 2017 [PMID: 28192579]
  24. Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL, de Souza-Galvão ML, Sánchez F, Rodrigo-Pendás JÁ, Noguera-Julian A, Martínez-Lacasa X, Tuñez MV, Fernández VL, Millet JP, Moreno A, Cobos N, Miró JM, Roldan L, Orcau A, Andersen P, Caylá JA. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial The Lancet. Respiratory medicine 2017 [PMID: 28159608]
  25. Arora G, Misra R, Sajid A. Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis Current topics in medicinal chemistry 2017 [PMID: 28137237]
  26. Clinton C, Sridhar D. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance Lancet (London, England) 2017 [PMID: 28139255]
  27. Chambers MA, Aldwell F, Williams GA, Palmer S, Gowtage S, Ashford R, Dalley DJ, Davé D, Weyer U, Salguero FJ, Nunez A, Nadian AK, Crawshaw T, Corner LA, Lesellier S. The Effect of Oral Vaccination with <i>Mycobacterium bovis</i> BCG on the Development of Tuberculosis in Captive European Badgers (<i>Meles meles</i>) Frontiers in cellular and infection microbiology 7:6 2017 [PMID: 28174695]
  28. Egere U, Togun T, Sillah A, Mendy F, Otu J, Hoelscher M, Heinrich N, Hill PC, Kampmann B. Identifying children with tuberculosis among household contacts in The Gambia The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 21(1):46-52 2017 [PMID: 28157464]
  29. Sotgiu G, Sulis G, Matteelli A. Tuberculosis-a World Health Organization Perspective Microbiology spectrum 5(1) 2017 [PMID: 28185618]
  30. Scriba TJ, Coussens AK, Fletcher HA. Human Immunology of Tuberculosis Microbiology spectrum 5(1) 2017 [PMID: 28155806]
  31. Nasiruddin M, Neyaz MK, Das S. Nanotechnology-Based Approach in Tuberculosis Treatment Tuberculosis research and treatment 2017:4920209 2017 [PMID: 28210505]
  32. Białek W, Rudzki S, Iberszer P, Wronecki L. Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer Journal of ultrasonography 16(67):404-410 2016 [PMID: 28138411]
  33. Ravansalar H, Tadayon K, Ghazvini K. Molecular typing methods used in studies of <i>Mycobacterium tuberculosis</i> in Iran: a systematic review Iranian journal of microbiology 8(5):338-346 2016 [PMID: 28149495]
  34. Gupta D, Banerjee S, Pailan S, Saha P. In silico identification and characterization of a hypothetical protein of Mycobacterium tuberculosis EAI5 as a potential virulent factor Bioinformation 12(3):182-191 2016 [PMID: 28149053]
  35. Kløvgaard M, Nielsen NO, Sørensen TL, Bjerregaard P, Olsen B, Christesen HT. Children in Greenland: disease patterns and contacts to the health care system International journal of circumpolar health 75(1):32903 2016 [PMID: 28156369]
  36. Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence Pathogens & immunity 1(2):308-329 2016 [PMID: 28217762]

Nipah virus

  1. Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens Globalization and health 13(1):9 2017 [PMID: 28179007]

Plasmodium falciparum (Malaria)

  1. Ma C, Claude KM, Kibendelwa ZT, Brooks H, Zheng X, Hawkes M. Is maternal education a social vaccine for childhood malaria infection? A cross-sectional study from war-torn Democratic Republic of Congo Pathogens and global health :1-9 2017 [PMID: 28220714]
  2. Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Kc N, Murshedkar T, Mendoza FH, Gordon IJ, Zephir KL, Holman LA, Plummer SH, Hendel CS, Novik L, Costner PJ, Saunders JG, Berkowitz NM, Flynn BJ, Nason MC, Garver LS, Laurens MB, Plowe CV, Richie TL, Graham BS, Roederer M, Sim BK, Ledgerwood JE, Hoffman SL, Seder RA. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28223498]
  3. Fried M, Duffy PE. Malaria during Pregnancy Cold Spring Harbor perspectives in medicine 2017 [PMID: 28213434]
  4. Dotsey E, Ushach I, Pone E, Nakajima R, Jasinskas A, Argueta DA, Dillon A, DiPatrizio N, Davies H, Zlotnik A, Crompton PD, Felgner PL. Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice Scientific reports 7:42584 2017 [PMID: 28209996]
  5. Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, Kamate B, Samake Y, Guindo MA, Dolo A, Niangaly A, Niaré K, Zeguime A, Sissoko K, Diallo H, Thera I, Ding K, Fay MP, O'Connell EM, Nutman TB, Wong-Madden S, Murshedkar T, Ruben AJ, Li M, Abebe Y, Manoj A, Gunasekera A, Chakravarty S, Sim BK, Billingsley PF, James ER, Walther M, Richie TL, Hoffman SL, Doumbo O, Duffy PE. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial The Lancet. Infectious diseases 2017 [PMID: 28216244]
  6. Paul G, Deshmukh A, Kaur I, Rathore S, Dabral S, Panda A, Singh SK, Mohmmed A, Theisen M, Malhotra P. A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites Malaria journal 16(1):79 2017 [PMID: 28202027]
  7. Kou X, Zheng W, Du F, Liu F, Wang M, Fan Q, Cui L, Luo E, Cao Y. Erratum to: Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine Parasites & vectors 10(1):84 2017 [PMID: 28209188]
  8. Greenwood B. Progress with the PfSPZ Vaccine for malaria The Lancet. Infectious diseases 2017 [PMID: 28215347]
  9. Mordmüller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, Held J, Calle CL, Mengue JB, Gebru T, Ibáñez J, Sulyok M, James ER, Billingsley PF, Natasha KC, Manoj A, Murshedkar T, Gunasekera A, Eappen AG, Li T, Stafford RE, Li M, Felgner PL, Seder RA, Richie TL, Sim BK, Hoffman SL, Kremsner PG. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine Nature 2017 [PMID: 28199305]
  10. Chen L, Xu Y, Wong W, Thompson JK, Healer J, Goddard-Borger E, Lawrence MC, Cowman AF. Structural basis for inhibition of erythrocyte invasion by antibodies to <i>Plasmodium falciparum</i> protein CyRPA eLife 6 2017 [PMID: 28195530]
  11. Favuzza P, Guffart E, Tamborrini M, Scherer B, Dreyer AM, Rufer AC, Erny J, Hoernschemeyer J, Thoma R, Schmid G, Gsell B, Lamelas A, Benz J, Joseph C, Matile H, Pluschke G, Rudolph MG. Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody eLife 6 2017 [PMID: 28195038]
  12. Kazmin D, Nakaya HI, Lee EK, Johnson MJ, van der Most R, van den Berg RA, Ballou WR, Jongert E, Wille-Reece U, Ockenhouse C, Aderem A, Zak DE, Sadoff J, Hendriks J, Wrammert J, Ahmed R, Pulendran B. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28193898]
  13. Galaway F, Drought LG, Fala M, Cross N, Kemp AC, Rayner JC, Wright GJ. P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5 Nature communications 8:14333 2017 [PMID: 28186186]
  14. Islami F, Torre LA, Drope JM, Ward EM, Jemal A. Global cancer in women: Cancer control priorities Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 [PMID: 28183824]
  15. Pichyangkul S, Spring MD, Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, Ubalee R, Vanachayangkul P, Remarque EJ, Angov E, Smith PL, Saunders DL. Chemoprophylaxis with sporozoite immunization in P. knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver PloS one 12(2):e0171826 2017 [PMID: 28182750]
  16. Obaldia N 3rd, Stockelman MG, Otero W, Cockrill JA, Ganeshan H, Abot EN, Zhang J, Limbach K, Charoenvit Y, Doolan DL, Tang DC, Richie TL. A <i>Plasmodium vivax</i> plasmid DNA- and adenovirus-vectored malaria vaccine encoding blood stage antigens AMA1 and MSP1<sub>42</sub> in a prime/boost heterologous immunization regimen partially protects Aotus monkeys against blood stage challenge Clinical and vaccine immunology : CVI 2017 [PMID: 28179404]
  17. Alves E, Salman AM, Leoratti F, Lopez-Camacho C, Viveros-Sandoval ME, Lall A, El-Turabi A, Bachmann MF, Hill AV, Janse CJ, Khan SM, Reyes-Sandoval A. Evaluation of PvCelTOS as a pre-erythrocytic <i>P. vivax</i> vaccine Clinical and vaccine immunology : CVI 2017 [PMID: 28179403]
  18. Seow J, Morales RA, MacRaild CA, Krishnarjuna B, McGowan S, Dingjan T, Jaipuria G, Rouet R, Wilde KL, Atreya HS, Richards JS, Anders RF, Christ D, Drinkwater N, Norton RS. Structure and characterisation of a key epitope in the conserved C-terminal domain of the malaria vaccine candidate MSP2 Journal of molecular biology 2017 [PMID: 28189425]
  19. Nash S, Mentzer AJ, Lule SA, Kizito D, Smits G, van der Klis FR, Elliott AM. The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial PLoS neglected tropical diseases 11(2):e0005213 2017 [PMID: 28178298]
  20. Rodrigues-da-Silva RN, Soares IF, Lopez-Camacho C, Martins da Silva JH, Perce-da-Silva DS, Têva A, Ramos Franco AM, Pinheiro FG, Chaves LB, Pratt-Riccio LR, Reyes-Sandoval A, Banic DM, Lima-Junior JD. <i>Plasmodium vivax</i> Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants Frontiers in immunology 8:77 2017 [PMID: 28223984]
  21. Dondorp AM, Smithuis FM, Woodrow C, Seidlein LV. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria Trends in parasitology 2017 [PMID: 28187990]
  22. Chen SB, Wang Y, Kassegne K, Xu B, Shen HM, Chen JH. Whole-genome sequencing of a Plasmodium vivax clinical isolate exhibits geographical characteristics and high genetic variation in China-Myanmar border area BMC genomics 18(1):131 2017 [PMID: 28166727]
  23. Diallo A, Sié A, Sirima S, Sylla K, Ndiaye M, Bountogo M, Ouedraogo E, Tine R, Ndiaye A, Coulibaly B, Ouedraogo A, Faye B, Ba EH, Compaore G, Tiono A, Sokhna C, Yé M, Diarra A, Bahmanyar ER, De Boer M, Pirçon JY, Usuf EA. An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal Malaria journal 16(1):63 2017 [PMID: 28166794]
  24. Bitencourt Chaves L, Perce-da-Silva DS, Rodrigues-da-Silva RN, Martins da Silva JH, Cassiano GC, Machado RL, Pratt-Riccio LR, Banic DM, Lima-Junior JD. Plasmodium vivax Cell Traversal Protein for Ookinetes and Sporozoites (PvCelTOS) gene sequence and potential epitopes are highly conserved among isolates from different regions of Brazilian Amazon PLoS neglected tropical diseases 11(2):e0005344 2017 [PMID: 28158176]
  25. Plebanski M, Flanagan KL. The Economics of Malaria Vaccine Development Trends in parasitology 2017 [PMID: 28169112]
  26. Nehete PN, Nehete BP, Chitta S, Williams LE, Abee CR. Phenotypic and Functional Characterization of Peripheral Blood Lymphocytes from Various Age- and Sex-Specific Groups of Owl Monkeys (<i>Aotus nancymaae</i>) Comparative medicine 67(1):67-78 2017 [PMID: 28222841]
  27. Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ. Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants Molecular therapy : the journal of the American Society of Gene Therapy 25(2):547-559 2017 [PMID: 28153101]
  28. Elston JW, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak Public health 143:60-70 2017 [PMID: 28159028]
  29. Mkumbaye SI, Wang CW, Lyimo E, Jespersen JS, Manjurano A, Mosha J, Kavishe RA, Mwakalinga SB, Minja DT, Lusingu JP, Theander TG, Lavstsen T. The severity of Plasmodium falciparum infection is associated with transcript levels of var genes encoding EPCR-binding PfEMP1 Infection and immunity 2017 [PMID: 28138022]
  30. Jin J, Hjerrild KA, Silk SE, Brown RE, Labbé GM, Marshall JM, Wright KE, Bezemer S, Clemmensen SB, Biswas S, Li Y, El-Turabi A, Douglas AD, Hermans P, Detmers FJ, de Jongh WA, Higgins MK, Ashfield R, Draper SJ. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag' International journal for parasitology 2017 [PMID: 28153778]
  31. Clinton C, Sridhar D. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance Lancet (London, England) 2017 [PMID: 28139255]
  32. Chiabi A, Malangue B, Nguefack S, Dongmo FN, Fru F, Takou V, Angwafo F 3rd. The clinical spectrum of severe acute malnutrition in children in Cameroon: a hospital-based study in Yaounde, Cameroon Translational pediatrics 6(1):32-39 2017 [PMID: 28164028]
  33. Wamae KK, Ochola-Oyier LI. Implications from predicted B-cell and T-cell epitopes of Plasmodium falciparum merozoite proteins EBA175-RII and Rh5 Bioinformation 12(3):82-91 2016 [PMID: 28149040]
  34. Błaszkowska J, Góralska K. Clinical cases of parasitoses and fungal infections important from medical point of view Annals of parasitology 62(4):255-265 2016 [PMID: 28151608]
  35. Ngandu NK, Manda S, Besada D, Rohde S, Oliphant NP, Doherty T. Does adjusting for recall in trend analysis affect coverage estimates for maternal and child health indicators? An analysis of DHS and MICS survey data Global health action 9(1):32408 2016 [PMID: 28156887]

Salmonella

  1. Marks F, von Kalckreuth V, Aaby P, Adu-Sarkodie Y, El Tayeb MA, Ali M, Aseffa A, Baker S, Biggs HM, Bjerregaard-Andersen M, Breiman RF, Campbell JI, Cosmas L, Crump JA, Espinoza LM, Deerin JF, Dekker DM, Fields BS, Gasmelseed N, Hertz JT, Van Minh Hoang N, Im J, Jaeger A, Jeon HJ, Kabore LP, Keddy KH, Konings F, Krumkamp R, Ley B, Løfberg SV, May J, Meyer CG, Mintz ED, Montgomery JM, Niang AA, Nichols C, Olack B, Pak GD, Panzner U, Park JK, Park SE, Rabezanahary H, Rakotozandrindrainy R, Raminosoa TM, Razafindrabe TJ, Sampo E, Schütt-Gerowitt H, Sow AG, Sarpong N, Seo HJ, Sooka A, Soura AB, Tall A, Teferi M, Thriemer K, Warren MR, Yeshitela B, Clemens JD, Wierzba TF. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study The Lancet. Global health 5(3):e310-e323 2017 [PMID: 28193398]
  2. Kishikawa S, Sato S, Kaneto S, Uchino S, Kohsaka S, Nakamura S, Kiyono H. Allograft inflammatory factor 1 is a regulator of transcytosis in M cells Nature communications 8:14509 2017 [PMID: 28224999]
  3. Cho H, Park NH, Jang Y, Gwon YD, Cho Y, Heo YK, Park KH, Lee HJ, Choi TJ, Kim YB. Fusion of Flagellin 2 with Bivalent White Spot Syndrome Virus Vaccine Increases Survival in Freshwater Shrimp Journal of invertebrate pathology 2017 [PMID: 28216094]
  4. Necchi F, Saul A, Rondini S. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout PloS one 12(2):e0172163 2017 [PMID: 28192483]
  5. Bornstein K, Hungerford L, Hartley D, Sorkin JD, Tapia MD, Sow SO, Onwuchekwa U, Simon R, Tennant SM, Levine MM. Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa PLoS neglected tropical diseases 11(2):e0005283 2017 [PMID: 28182657]
  6. Kumar A, Kundu S, Debnath Das M. Expression, purification and evaluation of recombinant lipoprotein of Salmonella typhi as a vaccine candidate Biologicals : journal of the International Association of Biological Standardization 2017 [PMID: 28189484]
  7. Zheng JH, Nguyen VH, Jiang SN, Park SH, Tan W, Hong SH, Shin MG, Chung IJ, Hong Y, Bom HS, Choy HE, Lee SE, Rhee JH, Min JJ. Two-step enhanced cancer immunotherapy with engineered <i>Salmonella typhimurium</i> secreting heterologous flagellin Science translational medicine 9(376) 2017 [PMID: 28179508]
  8. Kintz E, Heiss C, Black I, Donohue N, Brown N, Davies MR, Azadi P, Baker S, Kaye PM, van der Woude M. Salmonella Typhi Lipopolysaccharide O-antigen Modifications Impact on Serum Resistance and Antibody Recognition Infection and immunity 2017 [PMID: 28167670]
  9. Dobinson HC, Gibani MM, Jones C, Thomaides-Brears HB, Voysey M, Darton TC, Waddington CS, Campbell D, Milligan I, Zhou L, Shrestha S, Kerridge SA, Peters A, Stevens Z, Podda A, Martin LB, D'Alessio F, Thanh DP, Basnyat B, Baker S, Angus B, Levine MM, Blohmke CJ, Pollard AJ. Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 28158395]
  10. Teague KD, Graham LE, Dunn JR, Cheng HH, Anthony N, Latorre JD, Menconi A, Wolfenden RE, Wolfenden AD, Mahaffey BD, Baxter M, Hernandez-Velasco X, Merino-Guzman R, Bielke LR, Hargis BM, Tellez G. In ovo evaluation of FloraMax®-B11 on Marek´s disease HVT vaccine protective efficacy, hatchability, microbiota composition, morphometric analysis, and Salmonella enteritidis infection in broiler chickens Poultry science 2017 [PMID: 28160004]
  11. Bielaszewska M, Rüter C, Bauwens A, Greune L, Jarosch KA, Steil D, Zhang W, He X, Lloubes R, Fruth A, Kim KS, Schmidt MA, Dobrindt U, Mellmann A, Karch H. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury PLoS pathogens 13(2):e1006159 2017 [PMID: 28158302]
  12. Won G, Kim TH, Lee JH. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli BMC veterinary research 13(1):40 2017 [PMID: 28143511]
  13. Kamble NM, Lee JH. Homologous prime-boost immunization with live attenuated Salmonella enterica serovar Senftenberg and its preventive efficacy against experimental challenge with various strains of S. Senftenberg BMC veterinary research 13(1):39 2017 [PMID: 28143524]
  14. Liu F, Tang X, Sheng X, Xing J, Zhan W. Construction and evaluation of an Edwardsiella tarda DNA vaccine encoding outer membrane protein C Microbial pathogenesis 104:238-247 2017 [PMID: 28137507]
  15. Jiang H, Hu Y, Yang M, Liu H, Jiang G. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium Immunobiology 2017 [PMID: 28187901]

Shigella

  1. Necchi F, Saul A, Rondini S. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout PloS one 12(2):e0172163 2017 [PMID: 28192483]

Variola major (Smallpox)

  1. McClenathan BM, Stewart DA, Spooner CE, Pathmasiri WW, Burgess JP, McRitchie SL, Choi YS, Sumner SC. Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics Vaccine 35(9):1238-1245 2017 [PMID: 28169076]
  2. Croce E, Hatz C, Jonker EF, Visser LG, Jaeger VK, Bühler S. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports Vaccine 35(9):1216-1226 2017 [PMID: 28162821]

Venezuelan equine encephalitis virus

  1. Taylor K, Kolokoltsova O, Ronca SE, Estes M, Paessler S. Live, Attenuated Venezuelan Equine Encephalitis Virus Vaccine (TC83) Causes Persistent Brain Infection in Mice with Non-functional αβ T-Cells Frontiers in microbiology 8:81 2017 [PMID: 28184218]

Vibrio cholerae

  1. Levine MM, Chen WH, Kaper JB, Lock M, Danzig L, Gurwith M. PaxVax CVD 103-HgR single-dose live oral cholera vaccine Expert review of vaccines 16(3):197-213 2017 [PMID: 28165831]
  2. Tobias J, Lebens M, Wai SN, Holmgren J, Svennerholm AM. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens Microbial pathogenesis 2017 [PMID: 28215587]
  3. Kim EJ, Yu HJ, Lee JH, Kim JO, Han SH, Yun CH, Chun J, Nair GB, Kim DW. Replication of <i>Vibrio cholerae</i> classical CTX phage Proceedings of the National Academy of Sciences of the United States of America 2017 [PMID: 28196886]
  4. Xu P, Kelly M, Vann WF, Qadri F, Ryan ET, Kovac P. Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look Chembiochem : a European journal of chemical biology 2017 [PMID: 28182850]
  5. Molaee N, Mosayebi G, Amozande-Nobaveh A, Soleyman MR, Abtahi H. Evolution of the Immune Response against Recombinant Proteins (TcpA, TcpB, and FlaA) as a Candidate Subunit Cholera Vaccine Journal of immunology research 2017:2412747 2017 [PMID: 28191473]

Click HERE to see the publications in the last month.